Stockreport

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced its financial results for the fourth qu [Read more]